NRx Pharmaceuticals

NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug Application for NRX-101 to Treat Chronic Pain

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) recenlty announced that FDA has given the company clearance to proceed with human trials to treat Chronic Pain under the Investigational New Drug (IND) …

NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug Application for NRX-101 to Treat Chronic Pain Read More




Traffic Alert

Digital Message Sign Installations Scheduled at Night Next Week on I-95 in Bucks, Delaware, Philadelphia Counties

GREATER PHILADELPHIA — The Pennsylvania Department of Transportation (PennDOT) announced that Digital Message Sign (DMS) installations and other construction activities will be performed at night next week on Interstate 95 …

Digital Message Sign Installations Scheduled at Night Next Week on I-95 in Bucks, Delaware, Philadelphia Counties Read More